GLP-1 receptor agonist
Dulaglutide clinical trials
Answer
Dulaglutide has 144 registered trials: 23 running, 102 completed, 3 stopped early. 61 posted results.
Trial registerClinicalTrials.gov and EU CTIS, read 2026-10-03
| Trial | Title | Status | Phase | Registered | Results |
|---|---|---|---|---|---|
| NCT07668336 Trial register | A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes | not yet recruiting participants | - | 2026-06-25 | - |
| 2025-524811-35-00 Trial register | J2A-MC-GZGY: A Phase 3, Randomized, Open-Label Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Once-Daily Oral Orforglipron Compared With Onc | Not stated | 3 | - | - |
| NCT07834398 Trial register | Weekly GLP-1 Receptor Agonists in Obese Individuals Without Diabetes | completed | 3 | 2026-09-22 | - |
| NCT06779929 Trial register | Comparative Study of Tirzepatide Versus Dulaglutide (SURPASS CVOT) or Semaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes | completed | - | 2025-01-17 | - |
| NCT07820111 Trial register | Comparative Study of Different Weekly GLP-1 Receptor Agonists Among Diabetic and Non-Diabetic Patients: Clinical Trial | completed | 3 | 2026-09-15 | - |
| NCT06851962 Trial register | Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes. | completed | - | 2025-02-28 | - |
| NCT07787936 Trial register | GLP-1/GIP Receptor Agonists in Obesity-Related HFpEF: The GLIDE-HF Registry | not yet recruiting participants | - | 2026-08-18 | - |
| NCT07313813 Trial register | A Study to Evaluate the Effect of Fasting Duration and Dulaglutide (LY2189265) Withholding on Gastric Retention in Participants With Type 2 Diabetes Mellitus | completed | - | 2026-01-02 | - |
| NCT05220917 Trial register | Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study | running, but no longer enrolling | - | 2021-12-22 | - |
| NCT05478707 Trial register | Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes | currently recruiting participants | - | 2022-07-28 | - |
| NCT06739122 Trial register | A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS) | currently recruiting participants | - | 2024-12-18 | - |
| NCT07702461 Trial register | Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor Agonists | currently recruiting participants | - | 2026-07-14 | - |
| NCT07417631 Trial register | Emulation of the REWIND Cardiovascular Outcomes Trial in Healthcare Claims Data. | completed | - | 2026-02-18 | - |
| NCT07417618 Trial register | INcreTin-based thERapies for Cardiovascular Event PrevenTion in Patients With and Without ASCVD (INTERCEPT-ASCVD) | completed | - | 2026-02-18 | - |
| NCT07619495 Trial register | Injectable Semaglutide vs Dulaglutide in Individuals at Cardiovascular Risk | completed | - | 2026-06-02 | - |
| NCT04255433 Trial register | A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes | completed | 3 | 2020-02-05 | Posted |
| NCT07677891 Trial register | Phase II Study of Switching From Dulaglutide to PG-102(MG12) in Type 2 Diabetes Mellitus | not yet recruiting participants | - | 2026-07-01 | - |
| NCT07319286 Trial register | Role of Glucagon-like Peptide-1 Receptor Agonists in Menstrual Irregularities in Adolescent Females With Type 1 Diabetes Mellitus | enrolling by invitation only | - | 2026-01-06 | - |
| NCT04731272 Trial register | GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance | currently recruiting participants | - | 2021-01-29 | - |
| NCT06324461 Trial register | GLP-1 Receptor Agonist for Reduction of Myocardial Injury After Non-cardiac Surgery | currently recruiting participants | - | 2024-03-22 | - |
| NCT07537088 Trial register | Efficacy and Safety of Triple Therapy With Dulaglutide, SGLT2 Inhibitors, and Finerenone in Chinese Adults With Type 2 Diabetes and Chronic Kidney Disease | not yet recruiting participants | - | 2026-04-17 | - |
| NCT07027969 Trial register | Metabolic Surgery for Atrial Fibrillation Elimination | not yet recruiting participants | 4 | 2025-06-11 | - |
| NCT05390892 Trial register | PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes | currently recruiting participants | - | 2022-05-19 | - |
| NCT06235086 Trial register | A Study of TG103 Injection Combined With Metformin in Treatment of Type 2 Diabetes Mellitus | completed | - | 2024-01-31 | - |
| NCT03498001 Trial register | Effects of GLP-1 Agonists on CArdiac Steatosis Evaluated by Magnetic Resonance Imaging | completed | - | 2018-03-30 | - |
| NCT07370922 Trial register | Glucagon-Like Peptide 1 Receptor Agonist in Diabetes Mellitus Management in Children and Adolescents With Transfusion-Dependent Thalassemia | completed | - | 2026-01-27 | - |
| NCT06500143 Trial register | Residual Gastric Content After Holding of Glucagon-like Peptide-1 Receptor Agonists Before Elective Surgery | completed | - | 2024-07-15 | - |
| NCT07325435 Trial register | Beta Cell Function in Type 2 Diabetes: Differential Effects of SGLT2 Inhibitors and GLIP-Receptor Agonists | running, but no longer enrolling | - | 2025-12-18 | - |
| NCT07309094 Trial register | Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD | currently recruiting participants | - | 2025-12-30 | - |
| NCT07282041 Trial register | Role of GLP1 RA Dulaglutide on Severe Intracranial Atherosclerosis | currently recruiting participants | - | 2025-12-15 | - |
| NCT07276763 Trial register | Impact of Discontinuing GLP-1 Receptor Agonists for Two Weeks Prior to Upper Endoscopy on the Risk of Gastric Retention | not yet recruiting participants | - | 2025-11-29 | - |
| NCT06533527 Trial register | Holding vs. Continuing Incretin-based Therapies Before Upper Endoscopy | completed | 4 | 2024-06-27 | Posted |
| NCT07088718 Trial register | Prediction of the SURPASS-CVOT Cardiovascular Outcome Trial in Healthcare Claims Data | completed | - | 2025-07-28 | - |
| NCT07096063 Trial register | Comparative Effectiveness of Tirzepatide and Semaglutide in Individuals at Cardiovascular Risk | completed | - | 2025-07-31 | - |
| NCT07188545 Trial register | Using Secondary Data to Evaluate Sex-based Heterogeneity of GLP-1 Agonists and SGLT2 Inhibitors on Cardiovascular-Kidney-Metabolic Health (CKMH) Outcomes in Rea | running, but no longer enrolling | - | 2025-09-16 | - |
| NCT06257966 Trial register | A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Dulaglutide in Combination Therapy Diabetes Mellitus Type 2 Patients With Metformin | running, but no longer enrolling | - | 2024-02-14 | - |
| NCT07156539 Trial register | A Phase 3 Study of HS-20094 in Patients With T2DM | not yet recruiting participants | - | 2025-09-05 | - |
| NCT07109700 Trial register | A Study of HDM1005 in Participants With T2DM Not Controlled With Diet/Exercise or Metformin | currently recruiting participants | - | 2025-08-07 | - |
| NCT05564039 Trial register | A Study of Tirzepatide (LY3298176) in Adult Participants With Type 2 Diabetes Switching From Dulaglutide (SURPASS-SWITCH) | completed | 4 | 2022-10-03 | Posted |
| NCT06901648 Trial register | A Study of HS-20094 in Patients With T2DM | completed | - | 2025-03-30 | - |
| NCT03492580 Trial register | A Study for Comparison of Canagliflozin Versus Alternative Antihyperglycemic Treatments on Risk of Heart Failure Hospitalization and Amputation for Participants | completed | - | 2018-04-10 | - |
| NCT05680129 Trial register | A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Dulaglutide in Participants With T2DM | completed | - | 2023-01-11 | - |
| NCT06148649 Trial register | Phase 2 Study of HEC88473 Injection in Subjects With Type 2 Diabetes Mellitus | completed | - | 2023-11-28 | - |
| NCT05254418 Trial register | Effects of GLP1-RA on Ectopic Fat Deposition in Chronic Kidney Disease | completed | - | 2022-02-24 | Posted |
| NCT05659537 Trial register | A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus in India | completed | - | 2022-12-21 | Posted |
| NCT04862234 Trial register | Perioperative Stress Hyperglycemia in General and Vascular Surgery Patients | terminated before completion | - | 2021-04-27 | Posted |
| NCT04515576 Trial register | A Study of LY3493269 in Participants With Type 2 Diabetes | completed | - | 2020-08-17 | Posted |
| NCT04387201 Trial register | GLP-1 Therapy: The Role of IL-6 Signaling and Adipose Tissue Remodeling in Metabolic Response | completed | - | 2020-05-13 | Posted |
| NCT05218915 Trial register | Basal Plus GLP1-ra on Glycemic Variability in CKD | completed | - | 2022-02-01 | - |
| NCT05516966 Trial register | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Subcutaneous Injections of HRS9531 in Patients With Type 2 Diabetes Mellitus | completed | - | 2022-08-26 | - |
| NCT06581120 Trial register | GLP_1 RA Ultrasound Study | enrolling by invitation only | - | 2024-09-03 | - |
| NCT06611904 Trial register | The Effect of Combined Dulaglutide and Dapagliflozin Treatment vs DPP-4 Inhibitors in Endothelial and Vascular Function in Patients With Type 2 Diabetes Mellitu | last verified some time ago; the register no longer confirms its status | - | 2024-09-25 | - |
| NCT05606913 Trial register | A Study of IBI362 in Participants With Type 2 Diabetes | completed | - | 2022-11-07 | - |
| 2022-500101-41-00 Trial register | A Phase 4, Randomized, Open-Label, Active-Controlled Study to Investigate the Efficacy and Safety of Switching From Weekly Dulaglutide to Weekly Tirzepatide in | Not stated | 4 | - | - |
| NCT06449235 Trial register | Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in Bangladesh | last verified some time ago; the register no longer confirms its status | - | 2024-06-07 | - |
| NCT03743025 Trial register | Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery Patients | terminated before completion | - | 2018-11-15 | Posted |
| NCT04809220 Trial register | A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes | completed | - | 2021-03-22 | Posted |
| NCT05407961 Trial register | A Study of LY3532226 in Participants With Type 2 Diabetes Mellitus | completed | - | 2022-06-07 | - |
| NCT06331286 Trial register | The Effect of Dulaglutide as an Adjuvant Therapy on Cognitive Function in Bipolar Disorder Patients With Obesity | last verified some time ago; the register no longer confirms its status | - | 2024-03-26 | - |
| NCT05136287 Trial register | SEMAGLUTIDE VERSUS GLP-1 RECEPTOR AGONISTS. EFFECTIVENESS , SAFETY AND QUALITY OF LIFE IN PATIENTS WITH DIABETES MELLITUS 2. OBSERVATIONAL, PROSPECTIVE AND MULT | completed | - | 2021-11-29 | - |
| NCT06120556 Trial register | Efficacy of Glucagon-like Peptide-1 Receptor Agonists According to Type 2 Diabetes Subtypes | completed | - | 2023-11-07 | - |
| NCT02759107 Trial register | A Study of Tirzepatide (LY3298176) in Healthy Participants and Participants With Type 2 Diabetes (T2DM) | completed | 1 | 2016-05-03 | Posted |
| NCT05377333 Trial register | A Study of LY3457263 Alone and in Combination With Dulaglutide (LY2189265) in Participants With Type 2 Diabetes | completed | - | 2022-05-17 | - |
| NCT04965506 Trial register | A Study of IBI362 in Chinese Patients With Type 2 Diabetes | completed | - | 2021-07-16 | - |
| NCT06182891 Trial register | Renoprotective Effects of Dulaglutide in Patients With Type 2 Diabetic Nephropathy | completed | - | 2023-12-27 | - |
| NCT05048719 Trial register | A Study of LY3502970 in Participants With Type 2 Diabetes Mellitus | completed | - | 2021-09-17 | Posted |
| NCT05990374 Trial register | Therapeutic Effects and Effects on Body Fat of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes for 1-4 Years | last verified some time ago; the register no longer confirms its status | NA | 2023-08-14 | - |
| NCT05946148 Trial register | Novel Antidiabetic Medications and Their Effect on Liver Steatosis (NAMELS-18) | completed | - | 2023-07-14 | - |
| NCT04867785 Trial register | A Study of LY3437943 in Participants With Type 2 Diabetes | completed | 2 | 2021-04-30 | Posted |
| NCT05161429 Trial register | BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabetes | last verified some time ago; the register no longer confirms its status | - | 2021-11-23 | - |
| NCT01511393 Trial register | An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC) | enrolling by invitation only | - | 2011-11-30 | - |
| NCT04591626 Trial register | A Study of Dulaglutide (LY2189265) in Chinese Participants With Type 2 Diabetes | completed | - | 2020-10-19 | Posted |
| NCT04200625 Trial register | Semaglutide vs Dulaglutide on Epicardial Adipose Tissue | completed | - | 2019-12-16 | - |
| NCT05005741 Trial register | The Effects of Glucose Control and Weight Loss Between Beinaglutide and Dulaglutide in Type 2 Diabetes With Overweight or Obesity. | last verified some time ago; the register no longer confirms its status | - | 2021-08-13 | - |
| NCT04189848 Trial register | Comparison of Injection Site Pain Experience for Semaglutide and Dulaglutide sc | completed | - | 2019-12-06 | Posted |
| NCT05140694 Trial register | Effect of Empagliflozin and Dulaglutide on MAFLD in Patients With T2D | last verified some time ago; the register no longer confirms its status | - | 2021-12-01 | - |
| NCT05492305 Trial register | Glucagon-like Peptide 1 (GLP1) Receptor Agonists and Mental Health | last verified some time ago; the register no longer confirms its status | - | 2022-08-08 | - |
| NCT03204396 Trial register | Smoking Cessation Facilitated by Glucagon-like Peptide-1 (GLP-1) Analogues | completed | - | 2017-07-02 | - |
| NCT04687514 Trial register | Effects of Glucagon-Like Peptide-1 Analogs on Sexuality | completed | - | 2020-12-29 | - |
| NCT05459285 Trial register | A Pharmacokinetic Study Comparing the 14028 Injection and TRULICITY® in Healthy Chinese Subjects | completed | - | 2022-07-14 | - |
| NCT04876027 Trial register | GLP-1 RAs in Patients With Polycystic Ovary Syndrome (PCOS) | completed | - | 2021-04-29 | - |
| NCT04893148 Trial register | Efficacy and Safety of iGlarLixi Versus Insulin Glargine Plus Dulaglutide in Patients With Type 2 Diabetes | last verified some time ago; the register no longer confirms its status | - | 2021-05-19 | - |
| NCT02963766 Trial register | A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes | completed | - | 2016-11-15 | Posted |
| NCT05348122 Trial register | A Study of TG103 Injection in Type 2 Diabetes Subjects | last verified some time ago; the register no longer confirms its status | - | 2022-04-27 | - |
| NCT03861052 Trial register | A Study of Tirzepatide (LY3298176) Compared to Dulaglutide in Participants With Type 2 Diabetes | completed | 3 | 2019-03-04 | Posted |
| NCT04374578 Trial register | Effect of Dulaglutide on Glycemic Variability in Patients With Type 2 Diabetes | completed | - | 2020-05-05 | - |
| NCT02787551 Trial register | Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FR | completed | - | 2016-06-01 | Posted |
| NCT04829903 Trial register | Dulaglutide Versus Liraglutide in Obese Type 2 Diabetic Adolescents Using Metformin | completed | - | 2021-04-02 | - |
| NCT04641312 Trial register | A Study of LY3457263 in Healthy Participants and Participants With Type 2 Diabetes | completed | - | 2020-11-23 | - |
| NCT03684642 Trial register | Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin | terminated before completion | - | 2018-09-26 | Posted |
| NCT04466904 Trial register | Multiple-dose Tolerability and Pharmacokinetic of IBI362 in Chinese Patients With T2DM | completed | - | 2020-07-10 | - |
| NCT03668470 Trial register | Dulaglutide and Insulin MicrosecretiON in Type 1 Diabetes | completed | - | 2018-09-12 | - |
| NCT03015220 Trial register | Safety and Efficacy of Oral Semaglutide Versus Dulaglutide Both in Combination With One OAD (Oral Antidiabetic Drug) in Japanese Subjects With Type 2 Diabetes | completed | - | 2017-01-09 | Posted |
| NCT04143802 Trial register | A Study of LY3437943 in Participants With Type 2 Diabetes Mellitus (T2DM) | completed | 1 | 2019-10-29 | - |
| NCT02846233 Trial register | Stepping-down Approach in Patients With Chronic Poorly-controlled Diabetes on Advanced Insulin Therapy? | completed | - | 2016-07-19 | Posted |
| NCT02597049 Trial register | A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus | completed | - | 2015-11-04 | Posted |
| NCT03495102 Trial register | A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes | completed | - | 2018-04-11 | Posted |
| NCT03724981 Trial register | A Study Comparing the Dulaglutide Pen and the Semaglutide Pen | completed | - | 2018-10-30 | Posted |
| NCT03444142 Trial register | Effect of Exenatide LAR or Dulaglutide on the Variability of 24-hour Heart Rate and Blood Pressure in Type 2 Diabetes | last verified some time ago; the register no longer confirms its status | - | 2018-02-23 | - |
| NCT04184947 Trial register | Cardiovascular Outcomes SGLT-2 Inhibitors Versus GLP-1 Receptor Agonists | completed | - | 2019-12-01 | - |
| NCT03590626 Trial register | Effect of Dulaglutide on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease | completed | - | 2018-07-18 | - |
| NCT02770885 Trial register | Effects of GLP-1 Analogues on Fluid Intake in Patients With Primary Polydipsia (The GOLD-Study) | completed | - | 2016-05-12 | - |
| NCT02648204 Trial register | Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes. | completed | - | 2016-01-06 | Posted |
| NCT01394952 Trial register | Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND) | completed | - | 2011-07-15 | Posted |
| NCT02152371 Trial register | A Study of Dulaglutide (LY2189265) in Participants With Type II Diabetes | completed | - | 2014-06-02 | Posted |
| NCT02750410 Trial register | A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes | completed | - | 2016-04-25 | Posted |
| NCT02973100 Trial register | A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin Monotherapy | completed | - | 2016-11-25 | Posted |
| NCT01621178 Trial register | A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease | completed | - | 2012-06-18 | Posted |
| NCT01644500 Trial register | A Study Comparing the Effects and Safety of Dulaglutide With Glimepiride in Type 2 Diabetes Mellitus | completed | - | 2012-07-19 | Posted |
| NCT01648582 Trial register | A Study Comparing the Effects and Safety of Dulaglutide With Insulin Glargine in Type 2 Diabetes Mellitus | completed | - | 2012-07-24 | Posted |
| NCT03315780 Trial register | A Study of the Glucodynamic Effects of Dulaglutide (LY2189265) in Japanese Participants With Type 2 Diabetes | completed | - | 2017-10-20 | Posted |
| NCT03131687 Trial register | A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Mellitus | completed | 2 | 2017-04-27 | Posted |
| NCT03363906 Trial register | A Study of Dulaglutide in Healthy Participants | completed | - | 2017-12-06 | Posted |
| NCT03648554 Trial register | Researching an Effect of GLP-1 Agonist on Liver STeatosis (REALIST) | last verified some time ago; the register no longer confirms its status | - | 2018-08-27 | - |
| NCT03962010 Trial register | A Phase 2, 12-Week, Double-Blind, Efficacy and Safety of GX-G6 in Patients With Uncontrolled Type 2 Diabetes Mellitus | last verified some time ago; the register no longer confirms its status | - | 2019-05-22 | - |
| NCT03959865 Trial register | GLP-1 REceptor Agonists and Real World EvIdeNce | last verified some time ago; the register no longer confirms its status | - | 2019-05-20 | - |
| NCT03824002 Trial register | Dulaglutide in Diabetic Patients, Relationship Between Arterial Stiffness, Endothelial Function, Clinical and Laboratory Variables | completed | - | 2019-01-31 | - |
| NCT03141632 Trial register | Effects of Glucagon Like Peptide 1 (GLP-1) Analogues on Fluid Intake | completed | - | 2017-05-05 | - |
| NCT01667900 Trial register | A Study of Dulaglutide in Chinese Participants | completed | - | 2012-08-17 | Posted |
| NCT01769378 Trial register | Study of How Dulaglutide Compares to Placebo in Participants With Type 2 Diabetes Who Are Also on Sulfonylurea Therapy (AWARD-8) | completed | - | 2013-01-16 | Posted |
| NCT01001104 Trial register | A Study of LY2189265 in Japanese Patients With Type 2 Diabetes | completed | - | 2009-10-22 | Posted |
| NCT01558271 Trial register | A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus | completed | - | 2012-03-20 | Posted |
| NCT00734474 Trial register | A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin | completed | - | 2008-08-12 | Posted |
| NCT01149421 Trial register | A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 Diabetes | completed | - | 2010-06-15 | Posted |
| NCT01468181 Trial register | A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus | completed | - | 2011-11-07 | Posted |
| NCT01064687 Trial register | A Study in Participants With Type 2 Diabetes Mellitus | completed | - | 2010-02-08 | Posted |
| NCT01075282 Trial register | A Study in Participants With Type 2 Diabetes Mellitus (AWARD-2) | completed | - | 2010-02-23 | Posted |
| NCT01126580 Trial register | A Study in Participants With Type 2 Diabetes Mellitus (AWARD-3) | completed | - | 2010-05-18 | Posted |
| NCT00630825 Trial register | A Study of Dose Titration of LY2189265 in Overweight Participants With Type 2 Diabetes Mellitus | completed | - | 2008-02-28 | Posted |
| NCT00791479 Trial register | Effects of LY2189265 on Glycemic Control in Participants With Type 2 Diabetes | completed | - | 2008-11-12 | Posted |
| NCT01524770 Trial register | A Study to Compare the Effect of Giving Dulaglutide Using an Auto-injector Versus a Manual Syringe | completed | - | 2012-02-02 | Posted |
| NCT01584232 Trial register | A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes Mellitus | completed | - | 2012-04-24 | Posted |
| NCT01624259 Trial register | A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes | completed | - | 2012-06-20 | Posted |
| NCT01191268 Trial register | A Study in Participants With Type 2 Diabetes Mellitus (AWARD-4) | completed | - | 2010-08-27 | Posted |
| NCT01250834 Trial register | LY2189265 and Atorvastatin Interaction Study | completed | - | 2010-11-29 | Posted |
| NCT01324388 Trial register | A Study of the Effect of LY2189265 on Two Blood Pressure Drugs | completed | - | 2011-03-25 | Posted |
| NCT01458210 Trial register | A Study of the Effect of Dulaglutide on How the Body Handles Oral Contraceptive in Healthy Female Participants | completed | - | 2011-10-24 | Posted |
| NCT01215968 Trial register | A Study to Evaluate the Effect of LY2189265 on the Speed at Which Food and Drink Leaves the Stomach in Patients With Type 2 Diabetes Mellitus | completed | - | 2010-10-05 | Posted |
| NCT01253304 Trial register | A Single Dose Study of LY2189265 in Subjects With Varying Degrees of Hepatic (Liver) Impairment | completed | - | 2010-12-01 | Posted |
| NCT01300260 Trial register | Effect of LY2189265 on Insulin Secretion in Response to Intravenous Glucose | completed | - | 2011-02-21 | Posted |
| NCT01301092 Trial register | A Study to Compare the Concentrations of LY2189265 After Different Methods of Administration to Healthy Volunteers. | completed | - | 2011-02-18 | Posted |
| NCT01408888 Trial register | A Study of LY2189265 and Sitagliptin in Participants With Type 2 Diabetes | completed | - | 2011-08-02 | Posted |
| NCT01432938 Trial register | A Study of the Effect of Dulaglutide on the Action of Warfarin in Healthy Participants | completed | - | 2011-09-13 | Posted |
| NCT01436201 Trial register | A Study of the Effect of Dulaglutide on How Body Handles Digoxin in Healthy Participants | completed | - | 2011-09-19 | Posted |
Source: ClinicalTrials.gov and EU CTIS, read 2026-10-03. Not medical advice.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.